Safety, efficacy, and outcomes of 90-yttrium radioembolization in combination with immune checkpoint inhibitors as a definitive first-line treatment approach in non-surgical hepatocellular carcinoma.

Safety, efficacy, and outcomes of 90-yttrium radioembolization in combination with immune checkpoint inhibitors as a definitive first-line treatment approach in non-surgical hepatocellular carcinoma. Article

Full Text via DOI: 10.1200/JCO.2025.43.4_suppl.617 Web of Science: 001417523400035

Cited authors

Grahovac A, Sandow T, Mizrahi J, Du LL, Vallejo-Calzada R, Gimenez J, Cohen A, Nunez K, Thevenot P

Authors

Publication date

2025

Published in

Journal of Clinical Oncology Journal

International Standard Serial Number (ISSN)

0732-183X

Number of pages

1

Start page

617

End page

617

Volume

43

Issue

4_SUPPL